Investor Telemetry Investments, L.L.C.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Telemetry Investments, L.L.C. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2020-02-13 13G/A XTNT / Xtant Medical Holdings, Inc. 796,826 752,915
2019-02-14 13G/A OREX / Orexigen Therapeutics, Inc. 1,255,061 1,295,844
2019-02-14 13G/A XTNT / Xtant Medical Holdings, Inc. 1,416,339 796,826
2018-02-14 13G/A XTNT / Xtant Medical Holdings, Inc. 1,416,339 1,416,339
2018-02-14 13G/A OREX / Orexigen Therapeutics, Inc. 1,234,339 1,255,061
2017-08-10 13G/A OREX / Orexigen Therapeutics, Inc. 1,234,339 1,234,339
2017-08-09 13G/A XTNT / Xtant Medical Holdings, Inc. 1,416,339 1,416,339
2017-08-03 13G OREX / Orexigen Therapeutics, Inc. 1,234,339
2017-08-01 13G XTNT / Xtant Medical Holdings, Inc. 1,416,339